The impact of baseline shifts towards the heart after image guidance on survival in lung SABR patients
AffiliationManchester Cancer Research Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, UK
MetadataShow full item record
AbstractBACKGROUND AND PURPOSE: A recent study of NSCLC patients showed small residual shifts of the high dose region towards/away from the heart after image-guidance were significantly related to overall survival. This study investigates whether the effect is observed in a SABR cohort, who have significantly different baseline outlook and are treated using an imaging protocol matching on the tumour rather than bony-anatomy alone. MATERIALS AND METHODS: 136 NSCLC patients treated with SABR were studied. The mean baseline shift of the tumour in the direction of the heart over the course of treatment was determined for each patient and used to categorise patients into risk groups. Kaplan-Meier survival curves were plotted and multivariable analysis performed to assess significance of the vector shift to the heart alongside common clinical variables. RESULTS: The vector shift to the heart was independent of all tested clinical variables. A significant difference was seen in patient survival, with patients with shifts towards the heart having significantly worse prognosis as compared to patients with shifts away. Multivariable analysis found a hazard ratio of 1.262 per mm (p?=?0.013) for the vector shift to the heart, i.e. for every 1?mm shift of the high dose region towards the heart there is a 1.262 higher chance of death. CONCLUSIONS: Baseline shifts towards the heart significantly correlate with overall survival in a cohort of NSCLC SABR patients, with increased risk with increasing shifts towards the heart. These results provide further evidence for the use of stricter heart dose planning constraints for thoracic radiotherapy and suggest a heart planning organ at risk volume may be required for SABR treatments to account for baseline shifts.
CitationJohnson-Hart C, Price G, Vasquez Osorio E, Faivre-Finn C, van Herk M. The impact of baseline shifts towards the heart after image guidance on survival in lung SABR patients. Radiother Oncol. 2019.
JournalRadiotherapy and Oncology
- Residual Setup Errors Towards the Heart After Image Guidance Linked With Poorer Survival in Lung Cancer Patients: Do We Need Stricter IGRT Protocols?
- Authors: Johnson-Hart CN, Price GJ, Faivre-Finn C, Aznar MC, van Herk M
- Issue date: 2018 Oct 1
- A comparison between accelerated hypofractionation and stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer (NSCLC): Results of a propensity score-matched analysis.
- Authors: Chiang A, Thibault I, Warner A, Rodrigues G, Palma D, Soliman H, Jain S, Poon I, Cheung P
- Issue date: 2016 Mar
- Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort.
- Authors: Soldà F, Lodge M, Ashley S, Whitington A, Goldstraw P, Brada M
- Issue date: 2013 Oct
- Impact of small residual setup errors after image guidance on heart dose and survival in non-small cell lung cancer treated with curative-intent radiotherapy.
- Authors: Johnson-Hart C, Price G, McWilliam A, Green A, Faivre-Finn C, van Herk M
- Issue date: 2020 Nov
- Stereotactic Ablative Body Radiotherapy Versus Radical Radiotherapy: Comparing Real-World Outcomes in Stage I Lung Cancer.
- Authors: Phillips I, Sandhu S, Lüchtenborg M, Harden S
- Issue date: 2019 Oct